Trending Topic

A digital rendering of a human brain with highlighted neural pathways and electric activity, visualizing brain function.
18 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Pavel Burko, Ilias Miltiadis, Mahsa Alavi

Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of both upper and lower motor neurons, which ultimately leads to muscle weakness, atrophy, spasticity and contractures.1 ALS typically manifests in the 50–60 years age range, although familial cases may present in late adolescence or early adulthood.2 The time from the first symptom to diagnosis is approximately 10–16 […]

2 mins

Blood Pressure and White Matter Hyperintensity Volume – A Review of the Relationship and Implications for Stroke Prediction and Prevention

Royya Modir, Hannah Gardener, Clinton B Wright
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jun 27th 2012 European Neurological Review, 2012;7(3):174–7 DOI: http://doi.org/10.17925/ENR.2012.07.03.174
Select a Section…
1

Abstract

Overview

A heavy burden of white matter hyperintensities (WMH) is a risk factor for stroke and vascular cognitive impairment making it important to understand their pathophysiology, aetiology and clinical implications. Ageing studies suggest a linear relationship between blood pressure (BP) and both WMH and microstructural integrity in normal-appearing white matter and, after age, hypertension is the strongest risk factor for WMH. Numerous large population-based observational studies have reported significant associations between elevated BP and WMH burden, however, the relative importance of systolic versus diastolic BP remains controversial. Limitations of prior studies include the use of only a single measurement of BP and oversimplifying hypertension as a dichotomous variable. Race/ethnic differences in the association between BP and WMH have been suggested, but most studies only included older Caucasians. Antihypertensive treatment has been demonstrated to slow WMH progression, but lowering BP in the elderly may also reduce brain perfusion in those with poor autoregulation. Ongoing trials aim to clarify the effects of BP treatment on WMH progression in multi-ethnic populations and the implications of these findings for stroke prevention require further study.

Keywords

Leukoaraiosis, vascular cognitive impairment, blood pressure, hypertension, cerebral small vessel disease, white matter hyperintensities

2

Article

With the ever-increasing availability and clinical use of brain magnetic resonance imaging (MRI), the frequency of white matter hyperintensities (WMH) has become more readily apparent. As a heavy burden of WMH has been shown to be an important risk factor for incident stroke as well as vascular cognitive impairment,1 it is important to understand the pathophysiology, aetiology and clinical implications of WMH volume. Evidence suggests that hypertension is the strongest modifiable risk factor for WMH2–8 and raises the possibility of both prevention and treatment strategies, but clinical trials are lacking and further studies are needed.

Neuroimaging
WMH are demonstrated on T2-weighted MRI sequences. These damaged regions are evidenced on the T2 sequence as high signal intensity, which appear bright.9 They are considered white matter lesions if hyperintense on T2-weighted, fluid-attenuated inversion recovery and proton density images, without prominent hypointensity on T1-weighted images.1 They indicate areas of increased brain water content in white matter tissue, but the degree of damage to axons and supporting cells is not clear and remains an area under study (see Pathology section below).9 Recent evidence using diffusion tensor imaging has suggested a linear relationship between blood pressure levels and the microstructural integrity of both normal-appearing white matter and white matter hyperintensities. In hypertensive patients, the microstructural integrity of the cerebral white matter is significantly more affected than in normotensive patients.10

Pathology of White Matter Hyperintensities
The most common areas affected by WMH are in the deep white matter of the cerebral hemispheres, especially in the distribution of end-arteries and arterioles that supply a border-zone territory with minimal irrigation by collateral vessels. In areas identified as hyperintensities on MRI, pathological studies have reported myelin pallor, loss of tissue density, myelin and axonal loss, and gliosis.11,12 These lesions are hypothesised to be caused by chronic hypoperfusion of the white matter due to low-grade vascular insufficiency resulting in ischaemia,12 and are often associated with structural changes of the vessels, including hyalinisation, tortuosity, elongation and narrowing with arteriosclerosis and lipohyalinosis.12,13 Many of these changes have been associated with hypertension.14

To view the full article in PDF or eBook formats, please click on the icons above.

2

References

  1. Debette S, Markus HS, The clinical importance of white
    matter hyperintensities on brain magnetic resonance
    imaging: systematic review and meta-analysis, BMJ,
    2010;341:c3666

  2. Breteler MMB, van Swieten JC, Bots ML, et al., Cerebral white
    matter lesions, vascular risk factors, and cognitive function in
    a population-based study: the Rotterdam Study, Neurology,
    1994;44:1246–52.

  3. Longstreth WT Jr, Manolio TA, Arnold A, et al., Clinical
    correlates of white matter findings on cranial magnetic
    resonance imaging of 3301 elderly people. The
    Cardiovascular Health Study, Stroke, 1996;27:1274–82.

  4. Liao D, Cooper L, Cai J, et al., The prevalence and severity of
    white matter lesions, their relationship with age, ethnicity,
    gender, and cardiovascular disease risk factors: the ARIC
    Study, Neuroepidemiology, 1997;16:149–62.

  5. Liao D, Cooper L, Cai J, et al., Presence and severity of
    cerebral white matter lesions and hypertension, its
    treatment, and its control. The ARIC Study. Atherosclerosis
    Risk in Communities Study, Stroke, 1996;27:2262–70.

  6. de Leeuw FE, de Groot JC, Oudkerk M, et al., A follow-up
    study of blood pressure and cerebral white matter lesions,
    Ann Neurol, 1999;46:827–33.

  7. Jeerakathil T, Wolf PA, Beiser A, et al., Stroke risk profile
    predicts white matter hyperintensity volume: the
    Framingham Study, Stroke, 2004;35:1857–61.

  8. Dufouil C, Chalmers J, Coskun O, et al., Effects of blood
    pressure lowering on cerebral white matter hyperintensities
    in patients with stroke: the PROGRESS (Perindopril Protection
    Against Recurrent Stroke Study) Magnetic Resonance
    Imaging Substudy, Circulation, 2005;112:1644–50.

  9. Ovbiagele B, Saver JL, Cerebral white matter hyperintensities
    on MRI: current concepts and therapeutic implications,
    Cerebrovascular Diseases, 2006;22(2–3):83–90.

  10. Gons RA, de Laat KF, van Norden AG, et al., Hypertension
    and cerebral diffusion tensor imaging in small vessel disease,
    Stroke, 2010;41:2801–6.

  11. Fazeka F, Kleinert R, Offenbacher H, et al., Pathologic
    correlates of incidental MRI white matter signal
    hyperintensities, Neurology, 1993;43:1683–9.

  12. Pantoni L, Garcia JH, Pathogeneisis of leukokaraiosis: a
    review, Stroke, 1997;28:652–9.

  13. Moody D, Sanamore WP, Bell MA, Does Tortuosity in cerebral
    arterioles impair down-autoregulation in hypertensives and
    elderly normotensives? A hypothesis and computer model,
    Clin Neurosurg, 1991;37:372–87.

  14. Ostrow PT, Miller LL, Pathology of small artery disease,
    Adv Neurol, 1993;62:93–123.

  15. Wardlaw JM, Sandercock PAG, Dennis MS, Starr J, Is
    breakdown of the blood-brain barrier responsible for
    lacunar stroke, leukoaraiosis, and dementia?, Stroke,
    2003;34:806–11.

  16. Pantoni L, Garcia JH, The significance of cerebral white
    matter abnormalities 100 years after Binswanger’s report. A
    review, Stroke, 1995;26:1293–301.

  17. Wright CB, Moon Y, Paik MC, et al., Inflammatory biomarkers
    of vascular risk as correlates of leukoariosis, Stroke,
    2009;40:3466–71.

  18. Moody DM, Brown WR, Challa VR, Anderson RL,
    Periventricular venous collagenosis: association with
    leukoaraiosis, Radiology, 1995;194:469–76.

  19. Ylikoski A, Erkinjuntti T, Raininko R, et al., White matter
    hyperintensities on MRI in the neurologically nondiseased
    elderly. Analysis of cohorts of consecutive subjects aged
    55 to 85 years living at home, Stroke, 1995;26:1171–7.

  20. Garde E, Mortensen EL, Krabbe K, et al., Relation between
    age-related decline in intelligence and cerebral white-matter
    hyperintensities in healthy octogenarians: a longitudinal
    study, Lancet, 2000;356:628–34.

  21. Bots ML, van Swieten JC, Breteler MMB, et al., Cerebral
    white matter lesions and atherosclerosis in the Rotterdam
    Study, Lancet, 1993;341:1232–7.

  22. Lindgren A, Roijer A, Rudling O, et al., Cerebral lesions on
    magnetic resonance imaging, heart disease, and vascular
    risk factors in subjects without stroke: a population-based
    study, Stroke, 1994;25:929–34.

  23. Hajjar I, Kotchen TA, Trends in prevalence, awareness,
    treatment, and control of hypertension in the United States,
    1988–2000, JAMA, 2003;290:199–206.

  24. Dufouil C, de Kersaint-Gilly A, Besancon V, et al.,
    Longitudinal study of blood pressure and white matter
    hyperintensities: the EVA MRI Cohort, Neurology,
    2001;56:921–6.

  25. de Leeuw FE, de Groot JC, Oudkerk M, et al., Hypertension
    and white matter lesions in a prospective cohort study,
    Brain, 2002;125;765–72.

  26. Launer LJ, Masaki K, Petrovitch H, et al., The association
    between midlife blood pressure levels and late-life
    cognitive function: The Honolulu-Asia Aging Study, JAMA,
    1995;274:1846–51.

  27. Marcus J, Gardener H, Rundek T, et al., Baseline and
    longitudinal increases in diastolic blood pressure are
    associated with greater white matter hyperintensity
    volume: the Northern Manhattan study, Stroke,
    2011;42(9):2639–41.

  28. Guo X, Pantoni L, Simoni M, et al., Blood pressure
    components and changes in relation to white matter
    lesions: a 32-year prospective population study,
    Hypertension, 2009;54:57–62.

  29. Pinto E, Blood Pressure and ageing, Postgrad Med J,
    2007;83:109–14.

  30. Benetos A, Thomas F, Safar ME, et al., Should diastolic and
    systolic blood pressure be considered for cardiovascular
    risk evaluation: a study on middle-aged men and women,
    J Am Coll Cardiol, 2001;37:163–8.

  31. Godin O, Tzourio C, Maillard P, et al., Antihypertensive
    treatment and change in blood pressure are associated with
    the progression of white matter lesion volumes: the three-city
    (3C)-dijon magnetic resonance imaging study, Circulation,
    2011;123:266–73.

  32. Gottesman RF, Coresh J, Catellier DJ, et al., Blood pressure
    and white-matter disease progression in a biethnic cohort:
    Atherosclerosis Risk in Communities (ARIC) Study, Stroke,
    2010;41:3–8.

3

Article Information

Disclosure

The authors have no conflicts of interest to declare.

Correspondence

Clinton B Wright, Department of Neurology, Evelyn F McKnight Brain Institute, Leonard M Miller School of Medicine, University of Miami, CRB 1349, 1120 NW 14th Street, Miami, FL 33136, US. E: cwright@med.miami.edu

Received

2011-12-01T00:00:00

4

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup